Clinical Studies

Ongoing Studies

NYX-2925

Phase 2 – Painful Diabetic Peripheral Neuropathy

A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Multiple-Dose Study to Assess the Efficacy and Safety of NYX-2925 in Subjects with Neuropathic Pain Associated with Diabetic Peripheral Neuropathy — For more information, visit www.clinicaltrials.gov

Phase 2 – Fibromyalgia (Exploratory)

A Single-Blind, Exploratory, Placebo-controlled, Pilot Study to Assess the Efficacy and Safety of Daily Oral NYX-2925 in Subjects with Fibromyalgia — For more information, visit www.clinicaltrials.gov